ENAapplication/xmlprimaryOK200Genomics13-3935Vavilov Institute of General Geneticshttps://www.ebi.ac.uk/ena/browser/view/PRJNA268716Mycobacterium tuberculosisThis isolate (13-3935) was sensitive to first- and second line of antiTB drugs, included: isoniazid, rifampicin, ethambutol, pyrazinamide, ethionamide, amikacin, capreomycin, levofloxacin. Mycobacterium tuberculosis isolate 13-3935 was isolated in 2013 from the 30-years-old male patient from Moscow, with newly diagnosed infiltrative tuberculosis.pathogen:prioritypathogen:bacteriumpathogenbacteriaENAstrain, Bacillus tuberculosis, Bacterium tuberculosis, Mycobacterium tuberculosis (Zopf 1883) Lehmann and Neumann 1896 (Approved Lists 1980), Mycobacterium tuberculosis var. hominis, Mycobacterium tuberculosis H37Rv, Strain, Sprain, cultivar, Strains, whole genome, Sprains, Strains and Sprains, ecotype, Mycobacterium tuberculosis typus humanus, Genomes.strain, Bacillus tuberculosis, Bacterium tuberculosis, Mycobacterium tuberculosis (Zopf 1883) Lehmann and Neumann 1896 (Approved Lists 1980), Mycobacterium tuberculosis var. hominis, Mycobacterium tuberculosis H37Rv, Sprain, Strain., cultivar, Strains, Sprains, Strains and Sprains, ecotype, Mycobacterium tuberculosis typus humanusfalseMycobacterium tuberculosis strain:13-3935Mycobacterium tuberculosis strain:13-3935 Genome sequencing and assembly2025-09-242014-11-30PRJNA2687161773